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ORIGINAL ARTICLE
Gestational diabetes mellitus and the predisposing factors
Syeda Sadia Fatima,1 Rehana Rehman,2 Faiza Alam,3 Sarosh Madhani,4 Bushra Chaudhry,5 Taseer Ahmed Khan6

Abstract
Objective: To evaluate the occurrence of gestational diabetes mellitus and its association with demographic and
anthropometric variables in pregnant women.
Methods: This cross-sectional study was conducted at the Aga Khan University Hospital, Abbasi Shaheed Hospital
and Memon Hospital in Karachi, from February 2014 to December 2015, and comprised pregnant women who were
screened by 75-g 2-hour oral glucose tolerance test, (24-28 weeks of gestation) and classified as per the criteria of
the International Association of Diabetes and Pregnancy Study Group. Weight, body mass index and serum glycated
haemoglobin levels were measured. Women with pre-gestational diabetes were excluded. SPSS 21 was used for
data analysis.
Results: Of the 1,210 participants, 208(17.2%) had gestational diabetes, while 1,002(82.8%) did not have the
condition. Gestational diabetes was associated with advancing age, deranged glycated haemoglobin, elevated
body mass index at booking (p<0.001) and history of first-degree type 2 diabetic relatives (p=0.05). When stratified
according to ethnicities, no difference was observed in terms of gestational diabetes predilection among those who
had the condition (p>0.05).
Conclusion: Pre-existing adiposity and presence of strong family history rendered a considerable number of
pregnant women to suffer from gestational diabetes.
Keywords: Gestational diabetes mellitus, Pregnancy, The International Association of Diabetes and Pregnancy
Study Groups, IADPSG, Obesity, Body mass index, BMI. (JPMA 67: 261; 2017)

Introduction
Pregnancy convenes a state of insulin resistance and
hyper-insulinemia due to insufficient pancreatic function
required to overcome the diabetogenic milieu of
pregnancy. Gestational diabetes mellitus (GDM) is defined
as glucose intolerance that was not existing or known
before pregnancy.1 It is a worldwide phenomenon with
almost 15% of women suffering from hyperglycaemia
during pregnancy.2 The onset is associated with a large
number of foetal and maternal complications leading to
maternal, foetal and neonatal morbidity as well as
mortality. Some of the complications include preterm
birth, excessive birth weight, respiratory distress
syndrome, hypoglycaemia (due to excessive insulin levels
in baby) and risk of developing type 2 diabetes mellitus
(T2DM) later in life. The mother is also not spared from the
devastating effects of this disease. She can develop a
number of allied complications like high blood pressure,
pre-eclampsia and future diabetes. All these wellestablished risks demand a pertinent solution for early
detection and prevention of the disease.2
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Shifting the focus from global to more local perspectives
particularly the subcontinent, we see a variation of
prevalence in GDM. In India, the prevalence in urban areas
is 16.9% whereas in rural areas it is 9.9%,3 recently a
prevalence of 24% was reported using the current
International Association of Diabetes and Pregnancy
Study Groups (IADPSG) criteria for diagnosing GDM.4 The
prevalence in Bangladesh has been reported to be around
10%,5 while researchers from Nepal have reported a
prevalence of around 1% only.6
In Pakistan, the disease goes mostly unnoticed with no
significant data available to date about the prevalence of
this disease and development of preventive strategies.
Conflicting results are available from within Pakistan
showing a varied prevalence ranging from as high as 26%
in Peshawar,7 4.2% and 8% in Karachi,8,9 <1% in primary
gravid females from Lahore,10 22% in Balochistan,11 14%
in Bahawalpur12 and 14.8% in Hyderabad.13 It is, however,
difficult to project true numbers since these studies
recruited limited number of subjects and implied
different diagnostic criteria for the identification of GDM.
Adiposity, sedentary lifestyle and advancing maternal age
are some of the prospective causal factors, but
information about risk factors for GDM is scarce in
published large data set. The current study was planned
to gather data related to GDM frequency with reference to
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demographic and anthropometric variables.

Patients and Methods
This cross-sectional study was conducted at the antenatal
care clinics of the Aga Khan University Hospital, Abbasi
Shaheed Hospital and Memon Hospital in Karachi, from
February 2014 to December 2015, and comprised
pregnant women who were in their late second trimester.
Convenient random sampling was used. The institutional
ethics committees approved the research protocol and
written informed consent was obtained from all the
participants. The sample size was calculated using the
OpenEpi software.14 For a power of 80% with a 15%
estimated prevalence of GDM and a two-sided 5% level of
significance, the minimum sample size required was 418.
Women with pre-gestational diabetes, corticosteroid
therapy, history of asthma or hypertension, known foetal
anomaly, history of previous stillbirth and preterm
delivery were excluded. All women were interviewed on
educational background, socioeconomic status,15
sedentary lifestyle,16,17 family history of T2DM, previous
GDM, bad obstetric history and previous or current use of
any drug.
Participants' weight at booking was recorded from the
patient record cards, while current weight of subjects was
measured in kilogram on a digital weighing scale.
Standing body height was calculated without shoes by
height scale (floor type ZT-120 EVERICH, China) and body
mass index (BMI) was calculated (weight in kg/height in
m2).
They were then screened by 75-g 2-hour oral glucose
tolerance test (OGTT; 24-28 weeks of gestation). The
criteria used to diagnose GDM in patients were the ones
set by the IADPSG. The IADPSG was designed to enhance
research and training regarding GDM and T2DM during
gestation resulting in a better care.1 The IADPSG proposed
that all women should be screened for diabetes during
pregnancy and if not possible at least females falling in
the high-risk category should be screened. The plasma
glucose cut-off levels for diagnosing GDM were: fasting
glucose >92 mg/dL and/or 1 h: >180 mg/dL and/or 2 h:
>153 mg/dL. Subjects were considered to have GDM if
their plasma glucose levels were more than the cut-off
values. Normo-glycaemic pregnant women were
classified as controls for this study. Glycated haemoglobin
(HbA1c) levels of diagnosed GDM subjects were also
measured by commercially available kits.
SPSS 21 was used for data analysis. Descriptive analysis of
categorical data was presented as frequencies and
percentages whereas continuous variables were
expressed as mean ± standard deviation. Mann-Whitney
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U test and Pearson's chi-squared test/Fisher's exact test
and Pearson's correlation were applied. P<0.05 was
considered significant.

Results
Of the 1,210 participants, 208(17.2%) had GDM while
1,002(82.8%) were non-GDM. Moreover, 781(64.5%)
participants were primi-parous females. The mean age of
the GDM cohort was 27.94±5.84 years while that of nonGDM women was 25.58±4.59 years (p=0.761).
Haemoglobin level was 10.87±1.16 g/dl in the GDM and
10.48±1.17 in the non-GDM group (p=0.612). The OGTT
values at 0 and 2 hours were 112.27±21.62 mg/dl and
195.27±47.33 for the GDM cases versus 84.36±12.98
mg/dl and 125.89±13.74 for non-GDM subjects (p<0.001).
Table-1: Biophysical &biochemical parameters of the study cohort.
Variables

Age (year)
OGTT 0 hour (mg/dl)
OGTT 2 hour (mg/dl)
HbA1c (%)
BMI at Booking (kg/m2)
Haemoglobin (g/dl)
Positive Family History of T2DM
Parity
Primi Para
Multi Para
Grand Multipara
Sedentary Life Style
Socio- Economic/Income Status
Low (10-20 thousand)
Middle (21-100 thousand)
High (>100 thousand)
Treatment
Diet
Medication

Group A
Non-GDM
(n= 1002)
Mean ± SD

Group B
GDM
(n= 208)
Mean ± SD

P value

25.58 ± 4.59
84.36 ± 12.98
125.89 ± 13.74
NA
22.87 ± 4.22
10.48 ± 1.17
280 (27.9%)

27.94 ± 5.84
112.27 ± 21.62
195.27 ± 47.33
6.15 ± 1.49
25.68 ± 5.21
10.87 ± 1.16
92 (44.3%)

0.761
<0.001
<0.001
0.001
<0.001
0.612
0.001

n (%)
652 (65.0)
327 (32.7)
23 (2.3)
791 (78.9%)

n (%)
129 (62.0)
72 (34.6)
7 (3.4)
169 (81.2%)

0.648

333 (33.2)
415 (41.4)
255 (25.4)

62 (29.8)
69 (33.3)
77 (36.9)

0.02

NA
NA

110 (52.8%)
98 (47.2%)
Specific drug
Metformin 72/98
Insulin 22/98
Both 4/98

---

0.67

OGTT: Oral glucose tolerance test
BMI: Body mass index
T2DM: Type-2 diabetes mellitus
HbA1C: Glycated haemoglobin
GDM: Gestational diabetes mellitus
SD: Standard deviation
NA: Not available
Data expressed as Mean ± SD, absolute values and percentages in parenthesis. Mann-Whitney U
test and chi-square/Fisher's exact test is applied wherever applicable. P<0.05 is considered
significant.
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Table-2: Association of GDM.
Variables:
Age (year)
HbA1C (%)
BMI at booking (kg/m2)
Family History of T2DM

Pearson correlation

P value

0.224
0.261
0.230
0.281

<0.001
<0.001
<0.001
0.05

Pearson's correlation was applied to assess the relation between GDM and study parameters.
GDM: Gestational diabetes mellitus,
BMI: Body mass index
T2DM: Type-2 diabetes mellitus
HbA1C: Glycated haemoglobin.

Table-3: Distribution of study subjects according to ethnicity.
Ethnicity

Group A
Non-GDM
(n= 1002)

Group B
GDM
(n= 208)

Balochi
Punjabi
Pukhtoon
Sindhi
Mohajir (Urdu Speaking)
(61.5%)

114 (11.3%)
136 (13.6%)
71 (7.1%)
61 (6.1%)
620 (61.8%)

20 (9.6%)
27 (12.9%)
22 (10.6%)
11 (5.3%)
1 2 8

GDM: Gestational diabetes mellitus.

Similarly the GDM group had higher HbA1c and BMI
values than the non-GDM group (p<0.001). Besides,
92(44.3%) of GDM cases had a positive history of T2DM in
first-degree relatives versus 280(27.9%) non-GDM
subjects (p=0.001). Also, 169(81.2%) GDM cases followed
a sedentary lifestyle versus 791(79%) of non-GDM
subjects (p=0.67). Moreover, 484(40%) participants
belonged to the middle-income group, whereas
394(32.6%) and 332(27.4%) belonged to low- and highincome groups, respectively. Treatment options and
medications used to control for high glucose levels in
GDM subject showed that 110(52%) GDM subjects were
put on diet management while 98(47%) required
medicine for glycaemic control. Of the latter, 72(73.4%)
were prescribed metformin (at a daily dose of 500 mg
with meals initially), 22(22.4%) insulin-lispro (starting
dosage for non-obese patients was 0.8 U/kg and 0.9-1.0
U/kg in overweight and obese women, respectively) and
only 4(4.08%) required the use of both insulin and
metformin for glycaemic control. In the first two groups,
both doses were adjusted on the basis of blood glucose
monitoring (Table-1).
Correlation for GDM's association with the biophysical
parameters were calculated for age (0.224; p<0.001),
HbA1C (0.261; p<0.001), BMI (0.230; p<0.001) and family
history of T2DM (0.281: p=0.05) (Table-2).
Vol. 67, No. 2, February 2017

In the GDM group, 128(61.5%) participants were Mohajir,
27(12.9%) Punjabi, 20(9.6%) Balochi, 22(10.6%) Pukhtoon
and 11(5.3%) were Sindhi (p>0.05) (Table-3).

Discussion
In this study, we found that the pre-pregnancy BMI of
females with GDM was significantly higher than the
healthy controls (p<0.01). Furthermore, seventeen per
cent pregnant women were diagnosed with GDM in the
current study. The occurrence of GDM was associated with
advancing age, elevated BMI at booking (p<0.001) and
history of first-degree type 2 diabetic relatives. Our
findings are in accordance with the findings of various
other studies reporting that smoking, obesity and family
history of diabetes are the high risk factors for gestational
diabetes, along with advancing age, parity and previous
history of gestational diabetes,18,19 though we did not
find any association with the number of pregnancies and
GDM in our study. Out of these factors, pre-pregnancy
maternal obesity and excessive weight gain during
pregnancy are potentially modifiable, independent risk
factors that often occur in conjunction with GDM or
hyperglycaemia in pregnancy. The measurement of BMI
alone is not a true indicator of obesity in our population
due to different cut-offs used to define obesity.20
Moreover, compared with the white population, Asians
have a higher percentage of body fat at lower BMI,21 this
situation might lead to casualness by both the patient and
the doctor towards the effect of BMI on pregnancy and
might lead to early development of adverse effects during
pregnancy. This variation suggests there is a need to
incorporate a woman's race and body fat percentage
while developing prevention strategies for excess foetal
growth in women with GDM.
We observed that only 16.3% females had a previous
history of GDM whereas the majority developed GDM in
the recent pregnancy. We also inquired about their
previous history of complications i.e. macrosomia and
caesarean section deliveries related to GDM. It was noted
that 26.4% GDM subjects had previous macrosomic/large
for gestational age (LGA) babies resulting in more
caesarean sections as compared to healthy controls
(p<0.01). Contrary to our findings, no association between
obesity and gestational diabetes, foetal macrosomia and
the need for caesarean delivery were reported in a couple
of studies.22,23
It is believed that socially disadvantaged GDM women are
less likely to seek perinatal care and thus having more
pregnancy complications.24 Keeping this in mind, we
studied additional variables representing socioeconomic
status of these subjects and noticed that the majority
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belonged to high socioeconomic class. No association
between socioeconomic status or level of education and
GDM was identified by our group. Previous studies have
reported conflicting results due to different definitions
used for economic status depending upon the region of
research. Still, the prevalence of GDM has a weak but
significant relation with socioeconomic status including
education level, ethnicity, parity, maternal age, smoking,
nutrition, previous history of GDM and family history of
diabetes.25 As far as the effect of physical activity is
concerned, the majority of subjects reported a sedentary
lifestyle; hence we could not find an association of
lifestyle pattern with GDM. When stratified according to
ethnicities, 61.5% women in the GDM group were
Mohajir; 12.9% Punjabi, 9.6% Balochi, 10.6% Pukhtoon
and 5.3% were Sindhi. No association with GDM with the
different ethnicities was found in our study. Therefore, we
suggest that irrespective of ethnic background, all
Pakistani women are at risk of GDM and should be timely
screened.
Most of the GDM cases (52%) were put on medical
nutrition therapy (MNT) or diet control as a treatment
option, whereas 47% required the use of either metformin,
insulin or a combination therapy for blood glucose control.
The glycaemic status was identified by measuring the
HbA1c values for the GDM subjects. We found that both
treatment options were able to give a satisfactory glucose
control level (HbA1c ~6%) for majority of patients. In
addition to monitoring the glucose control, HbA1C is also
used to screen GDM and identify high risks of foetomaternal complications associated with it.1 Moreover,
latest investigation revealed that HbA1C values were not
affected by haemoglobin levels and can be used as a
reliable tool in pregnant women affected by anaemia.26
This new development is especially beneficial for our
population, as research reports that almost 51% pregnant
women suffer from anaemia.27 The HbA1c levels at 28
weeks of gestation can help in identifying females who
need careful and regular monitoring of glycaemic index.
Therefore, we suggest that measuring HbA1c could be
used both as a means for diagnosing and monitoring the
diabetic status of a subject.
Our study still needs to be expanded in order to have a
clear perception of the occurrence of GDM. One of the
limitations of the current study was that we did not follow
up these females to record various obstetric
complications like preterm birth, macrosomia and
caesarean section. We also did not repeat HbA1c after
delivery.
Despite these limitations, the study was the first multicentric survey carried out in the region that reports a GDM
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frequency of 17%; this alone hallmarks the necessity of
screening of all pregnant females. Screening and early
detection of GDM by either OGTT or HbA1C should be
exclusively implied in all pregnant women irrespective of
age, BMI and ethnicity in our population.
We recommend generating awareness of use of healthy
food and physical activity to maintain normal BMI in the
population in general. Also, screening and early detection
of GDM by either OGTT or HbA1C exclusively in all
pregnant women and frequent monitoring is
recommended for the prevention of a number of
maternal and neonatal complications.

Conclusion
A considerable number of pregnant women were
diagnosed as having GDM, which was associated with
pre-existing adiposity, progressing age, elevated BMI at
booking, existence of first-degree type 2 diabetic relatives
and history of GDM in previous pregnancies.
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